The effect of Qutenza application in patients with post-operative neuropathic pain: A double-blind, randomized, controlled pilot study - Qutenza-FM-20

Wojciech Zbigniew Pawlak0 个研究点目标入组 26 人开始时间: 2020年8月17日最近更新: 2022年1月17日

适应症

试验速览

暂无简介。

•Age > 18 years old
•Patients with chronic pain for =3 months, with a daily VAS pain scores =40 mm (VAS 0-100mm, 0=no pain and 100=worst possible pain) after sur-gery
•Patients have a score =7 in the neuropathic pain questionnaire DN4
•Negative pregnancy test in fertile women.
•Patients with at least one identifiable trigger point in relation to incision in a mobile body part or a positive outcome from our first study (7). A trigger point is defined as an area in relation to the incision from surgery, in which a light pressure from a cotton pin radiate pain to the nearby area and exudes a motor reflex causing withdrawal of the body part related to the incision. Trigger points will be identified using ultrasound scanning.
•Skin must be intact and dry without wounds or stripes in an area of 6 cm in diameter from the trigger point
•A written and signed informed consent to participate in the study after having fully understood the contents of the protocol and restrictions
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 20
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range 6

•Patients who cannot cooperate
•Patients who can cooperate but do not understand or speak Danish
•Patients with allergy to the drugs used in the study, ingredients or compo-nents in the matrix and cleansing creme*
•Women who are not using acceptable effective contraception
•Patients suffering from other neuropathic pain conditions.

发起方

Wojciech Zbigniew Pawlak